Irving-Based Biote to Be Listed on Nasdaq

Irving-based Biote, a medical practice-building business within the hormone optimization space, will be listed on Nasdaq through a business combination with Haymaker Acquisition Corp. III.

Biote—which will earn projected revenue of $136 million in 2021—trains practitioners to identify and treat early indicators of hormone-related aging conditions. The company then provides components that enable practitioners to establish, build, and successfully operate hormone optimization centers.

The implied initial equity value of the business combination is approximately $737 million.

“Biote has a huge opportunity to enable physicians to help this highly underserved patient population take greater control of their health,” said Terry Weber, CEO of Biote (above) in a statement. “Biote is committed to educating and empowering providers to effectively treat patients and help them understand the critical role that hormones play in healthy aging,”

The business combination is expected to be completed in the first half of 2022, with the combined company listed on Nasdaq under the ticker symbol BTMD.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.

R E A D   N E X T

  • Signature Biologics President and COO Chloe Bailey

    Rare is not that rare, says the RDCC. One in ten people lives with a rare disease, and the new coalition will unify life science companies dedicated to developing treatments. The goal? To inform policymakers of the unique challenges in the space. Signature Biologics joins Dallas-based Taysha as a member of the RDCC.

  • It’s the final step in a multi-year transition for the strategic communications firm launched by Gail Cooksey 28 years ago.  The agency is “in great hands,” the founder said.

  • The City of Irving has won silver certification from Bloomberg Philanthropies' What Works Cities—the national standard of well-managed cities recognizing the most effective use of data to inform policy and funding decisions. The honor comes in a year that's tested the mettle of municipalities nationwide. Since 2018, 40 cities have achieved the certification. This year 16 new cities were recognized, including gold-winning Austin and silver-winning San Antonio. “During the pandemic, using data to inform decision-making was more important than ever for cities," said Michael Bloomberg in a statement. “By putting data at the center of their COVID-19 response efforts, these cities saved lives and…

  • Irving-based Fluor receives $1.16B contract extension for Navy nuclear propulsion work [Photo: Fluor]

    When you think of Irving, you probably don't think "submarines." Well, you should start. Irving is home to the headquarters of Fluor, whose subsidiary Fluor Marine Propulsion got the one-year extension to work on naval nuclear propulsion technology at Navy Nuclear Laboratory sites in New York, Pennsylvania, and Idaho. 

  • There, Signature Biologics will manufacture perinatal-derived products that improve the body's natural healing processes in wound, musculoskeletal, and pain management applications.